CompletedNot Applicable

Impact of HPV Vaccine On The Prevalence Of HPV In Norway

Norway315 participantsStarted 2016-11

Plain-language summary

The overall aim of the study is to assess the effect of school-based Human Papillomavirus (HPV) vaccination by comparing type-specific HPV prevalence between vaccinated and non-vaccinated women born in 1997. Women born in 1997, residence to Norway in 2009 (the year of vaccine initiation of the 1997-cohort) are invited to participate in the study.

Who can participate

Age range18 Years – 20 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female * Born in 1997 * Resident of Norway in 2009 Exclusion Criteria: * Male * Born before or after 1997 * Non-resident of Norway in 2009

What they're measuring

Vaginal and oral HPV-6, HPV-11, HPV-16 and HPV-18 prevalence

Timeframe: Within 2 months after self-collection of specimens

Trial details

NCT IDNCT02934724

SponsorOslo University Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-02

View on ClinicalTrials.gov More Cervical Intraepithelial Neoplasia trials